Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 44
The potential function and clinical application of FGF21 in metabolic diseases
Zhiwei Chen, Lili Yang, Yang Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Neuregulin 4 as a novel adipokine in energy metabolism
Yuanbin Liu, Mingkai Chen
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 24
The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis
Susanne Schüler‐Toprak, Olaf Ortmann, Christa Buechler, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2503-2503
Open Access | Times Cited: 32
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
Shuo Li, Tiande Zou, Jun Chen, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101064-101064
Open Access | Times Cited: 15
Brown adipose tissue-derived metabolites and their role in regulating metabolism
Khanyisani Ziqubu, Phiwayinkosi V. Dludla, Sihle E. Mabhida, et al.
Metabolism (2023) Vol. 150, pp. 155709-155709
Closed Access | Times Cited: 14
Fibroblast growth factor 21: a novel link in the development and treatment of metabolic disorders
A. A. Mikhailova, Marina V. Sharypova, А. В. Симаненкова, et al.
Arterial’naya Gipertenziya (Arterial Hypertension) (2025) Vol. 30, Iss. 5, pp. 441-450
Open Access
Pathology and Therapeutic Significance of Fibroblast Growth Factors
Oshadi Edirisinghe, Gaëtane Ternier, Thallapuranam Krishnaswamy Suresh Kumar
Targets (2025) Vol. 3, Iss. 1, pp. 5-5
Open Access
A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction‐associated steatotic liver disease
Shifang Tang, Jürgen Borlak
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Ketogenic diet and ketone salts differentially improve cardiometabolic complications in an HFpEF rat model
Alexandre Gonçalves, Inês N. Alves, Cláudia Sousa-Mendes, et al.
The Journal of Physiology (2025)
Closed Access
Fibroblast growth factor 21 as a potential master regulator in metabolic disorders
Aayushi Velingkar, Sugunakar Vuree, Pranav Kumar Prabhakar, et al.
AJP Endocrinology and Metabolism (2023) Vol. 324, Iss. 5, pp. E409-E424
Closed Access | Times Cited: 11
Brown adipose tissue CoQ deficiency activates the integrated stress response and FGF21-dependent mitohormesis
Ching-Fang Chang, Amanda L. Gunawan, Irene Liparulo, et al.
The EMBO Journal (2024) Vol. 43, Iss. 2, pp. 168-195
Open Access | Times Cited: 4
The crosstalk between fibroblast growth factor 21 (FGF21) system and substance use
Tammy Wang, Ryan E. Tyler, Oyenike Ilaka, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110389-110389
Open Access | Times Cited: 4
Healthy adipose tissue after menopause: contribution of balanced diet and physical exercise
Bruno Vecchiatto, Thiago Lucas de Castro, Natália Juliana Ramos Ferreira, et al.
(2025)
Closed Access
Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
Namrita Kaur, Sanskruti Ravindra Gare, Jiahan Shen, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway
Manuel Arias‐Calderón, Mariana Casas, Julián Balanta‐Melo, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Effects of Empagliflozin‐Induced Glycosuria on Weight Gain, Food Intake and Metabolic Indicators in Mice Fed a High‐Fat Diet
Thu Anh Nguyen, Zachary Amigo, Kathleen McDuffie, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 3
Astrocytes as metabolic suppliers to support neuronal activity and brain functions
Hélène Roumes, Luc Pellerin, Anne‐Karine Bouzier‐Sore
Essays in Biochemistry (2022) Vol. 67, Iss. 1, pp. 27-37
Open Access | Times Cited: 13
Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
Tsu‐Kung Lin, Chi-Ren Huang, Kai-Jung Lin, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 2
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
Oshadi Edirisinghe, Gaëtane Ternier, Zeina Alraawi, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1622-1622
Open Access | Times Cited: 2
Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
Adrian Post, Wendy Dam, Sara Sokooti, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. 1387-1393
Open Access | Times Cited: 11
Mangiferin Ameliorates Obesity-Associated Inflammation and Autophagy in High-Fat-Diet-Fed Mice: In Silico and In Vivo Approaches
Ji-won Noh, Han-Young Lee, Byung-Cheol Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15329-15329
Open Access | Times Cited: 8
Exploring endocrine FGFs - structures, functions and biomedical applications
Phuc Phan, Gaёtane Ternier, Oshadi Edirisinghe, et al.
International Journal of Biochemistry and Molecular Biology (2024) Vol. 15, Iss. 4, pp. 68-99
Closed Access | Times Cited: 1
Clinical significance of serum FGF21 levels in diagnosing nonalcoholic fatty liver disease early
Kai Xu, Bo-Wu He, Jun Yu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Circulating FGF21 is lower in South Asians compared to Europids with type 2 diabetes mellitus
Carlijn A. Hoekx, Borja Martínez‐Téllez, Maaike E. Straat, et al.
Endocrine Connections (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top